Vista Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $816K | Sell |
6,388
-23
| -0.4% | -$2.87K | 0.27% | 100 |
|
|
2025
Q4 | $782K | Buy |
6,411
+10
| +0.2% | +$1.15K | 0.26% | 98 |
|
|
2025
Q3 | $641K | Sell |
6,401
-362
| -5% | -$32.6K | 0.22% | 109 |
|
|
2025
Q2 | $561K | Sell |
6,763
-1,784
| -21% | -$142K | 0.21% | 113 |
|
|
2025
Q1 | $693K | Sell |
8,547
-897
| -9% | -$80.2K | 0.27% | 101 |
|
|
2024
Q4 | $851K | Sell |
9,444
-1,203
| -11% | -$117K | 0.32% | 90 |
|
|
2024
Q3 | $1.05M | Sell |
10,647
-645
| -6% | -$63.4K | 0.4% | 76 |
|
|
2024
Q2 | $1.05M | Sell |
11,292
-33
| -0.3% | -$2.96K | 0.42% | 71 |
|
|
2024
Q1 | $1.07M | Sell |
11,325
-470
| -4% | -$43.6K | 0.44% | 70 |
|
|
2023
Q4 | $1.05M | Sell |
11,795
-2,023
| -15% | -$150K | 0.49% | 66 |
|
|
2023
Q3 | $1.01M | Sell |
13,818
-1,152
| -8% | -$92K | 0.53% | 62 |
|
|
2023
Q2 | $1.25M | Sell |
14,970
-245
| -2% | -$20.5K | 0.63% | 52 |
|
|
2023
Q1 | $1.16M | Buy |
15,215
+233
| +2% | +$19.3K | 0.61% | 54 |
|
|
2022
Q4 | $1.24M | Buy |
14,982
+331
| +2% | +$26.8K | 0.71% | 46 |
|
|
2022
Q3 | $1.16M | Buy |
14,651
+106
| +0.7% | +$8.94K | 0.72% | 45 |
|
|
2022
Q2 | $1.08M | Buy |
14,545
+371
| +3% | +$27.8K | 0.65% | 47 |
|
|
2022
Q1 | $1.27M | Buy |
14,174
+2,903
| +26% | +$268K | 0.7% | 47 |
|
|
2021
Q4 | $1.26M | Buy |
11,271
+413
| +4% | +$49.8K | 0.69% | 50 |
|
|
2021
Q3 | $1.36M | Buy |
10,858
+374
| +4% | +$48.2K | 0.8% | 40 |
|
|
2021
Q2 | $1.42M | Buy |
10,484
+271
| +3% | +$35.6K | 0.84% | 40 |
|
|
2021
Q1 | $1.39M | Buy |
10,213
+182
| +2% | +$27.2K | 0.86% | 38 |
|
|
2020
Q4 | $1.41M | Sell |
10,031
-1,463
| -13% | -$187K | 0.95% | 34 |
|
|
2020
Q3 | $1.28M | Sell |
11,494
-47
| -0.4% | -$5.27K | 0.98% | 35 |
|
|
2020
Q2 | $1.29M | Sell |
11,541
-80
| -0.7% | -$7.88K | 1.11% | 32 |
|
|
2020
Q1 | $900K | Buy |
11,621
+67
| +0.6% | +$5.93K | 0.92% | 35 |
|
|
2019
Q4 | $1.1M | Buy |
11,554
+434
| +4% | +$37.5K | 0.83% | 44 |
|
|
2019
Q3 | $848K | Buy |
11,120
+1,947
| +21% | +$162K | 0.7% | 48 |
|
|
2019
Q2 | $805K | Buy |
9,173
+2,161
| +31% | +$184K | 0.68% | 51 |
|
|
2019
Q1 | $635K | Buy |
7,012
+246
| +4% | +$20.9K | 0.56% | 66 |
|
|
2018
Q4 | $485K | Buy |
6,766
+3,740
| +124% | +$301K | 0.5% | 72 |
|
|
2018
Q3 | $290K | Hold |
3,026
| – | – | 0.26% | 121 |
|
|
2018
Q2 | $288K | Buy |
3,026
+100
| +3% | +$9.19K | 0.28% | 116 |
|
|
2018
Q1 | $257K | Buy |
2,926
+275
| +10% | +$25.1K | 0.27% | 113 |
|
|
2017
Q4 | $225K | Buy |
+2,651
| New | +$222K | 0.24% | 121 |
|
Other funds holding XBI
Vista Investment Management's XBI Position: Q1 2026 in Review
Vista Investment Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.36% in Q1 2026, selling an estimated $2.87K and leaving 6,388 shares worth $816K. The position accounts for 0.27% of the portfolio, ranked #100.
Vista Investment Management first reported a position in XBI in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.42M in Q2 2021. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Vista Investment Management held 6,388 shares of State Street SPDR S&P Biotech ETF worth $816K as of Q1 2026.
- Vista Investment Management sold 23 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $2.87K.
- State Street SPDR S&P Biotech ETF made up 0.27% of Vista Investment Management's portfolio in Q1 2026, its #100 holding.
- Vista Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 34 quarters since.
- Vista Investment Management's State Street SPDR S&P Biotech ETF position peaked at $1.42M in Q2 2021.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Vista Investment Management's 13F filing for Q1 2026, filed 15 May 2026.